TA
CHRS icon

Teachers Advisors’s Coherus Oncology CHRS Stock Holding History

Teachers Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$10.9M Buy
797,019
+22,891
+3% +$305K 0.01% 960
2018
Q4 		$7.01M Buy
774,128
+18,296
+2% +$212K 0.01% 1120
2018
Q3 		$12.5M Buy
755,832
+21,372
+3% +$379K 0.02% 974
2018
Q2 		$10.3M Buy
734,460
+611,309
+496% +$8.75M 0.01% 1072
2018
Q1 		$1.36M Buy
123,151
+25,657
+26% +$281K ﹤0.01% 2066
2017
Q4 		$858K Buy
97,494
+12,619
+15% +$135K ﹤0.01% 2322
2017
Q3 		$1.13M Buy
84,875
+264
+0.3% +$3.49K ﹤0.01% 2162
2017
Q2 		$1.21M Sell
84,611
-135,060
-61% -$2.6M ﹤0.01% 2118
2017
Q1 		$4.65M Buy
219,671
+71,918
+49% +$1.77M 0.01% 1332
2016
Q4 		$4.16M Buy
147,753
+2,374
+2% +$66.4K 0.01% 1377
2016
Q3 		$3.89M Sell
145,379
-865
-0.6% -$23.6K 0.01% 1350
2016
Q2 		$2.47M Buy
146,244
+11,942
+9% +$224K ﹤0.01% 1527
2016
Q1 		$2.85M Buy
134,302
+7,634
+6% +$125K 0.01% 1387
2015
Q4 		$2.91M Buy
126,668
+92,320
+269% +$2.38M 0.01% 1371
2015
Q3 		$688K Hold
34,348
– – ﹤0.01% 2199
2015
Q2 		$993K Buy
34,348
+27,858
+429% +$704K ﹤0.01% 2124
2015
Q1 		$198K Buy
6,490
+215
+3% +$5.56K ﹤0.01% 2880
2014
Q4 		$102K Buy
+6,275
New +$88.5K ﹤0.01% 3036

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Teachers Advisors's CHRS Position: Q1 2019 in Review

Teachers Advisors increased its Coherus Oncology (CHRS) stake by 3% in Q1 2019, buying an estimated $305K and bringing the position to 797,019 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #960.

Teachers Advisors first reported a position in CHRS in Q4 2014 and has held it in 18 quarters since. The position peaked at $12.5M in Q3 2018. 117 funds tracked by Wall St. Rank hold CHRS as of Q1 2019.

  • Teachers Advisors held 797,019 shares of Coherus Oncology worth $10.9M as of Q1 2019.
  • Teachers Advisors bought 22,891 Coherus Oncology shares in Q1 2019, an estimated $305K.
  • Coherus Oncology made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #960 holding.
  • Teachers Advisors first reported a position in Coherus Oncology in Q4 2014 and has held it in 18 quarters since.
  • Teachers Advisors's Coherus Oncology position peaked at $12.5M in Q3 2018.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.